TRT and High Hematocrit: What Your Number Means and What to Do Next

TRT and high hematocrit are linked because testosterone makes your body build more red blood cells. The Endocrine Society calls for prescriber-led action above 54%; lower but rising results still deserve review. Your symptoms, starting level and exact product change the next step. Contact your prescriber, rather than changing treatment or arranging repeated donations yourself. ¹

By TRT Provider Guide · Last verified October 2026 · Educational information, not medical advice. This page can't read your lab results or tell you how to change your treatment.

Last updated: October 5, 2026.

Editorial research; not clinician-reviewed.

The numbers that matter most: A lab's high flag, a study cutoff of 52%, and a guideline action point above 54% do different jobs. The product trials below also use different measures: Xyosted reported hematocrit increase in 14.0% of men in its one-year trial, while 4.2% across its two trials reached 55% or higher. Those are not the same outcome. ², ³, ⁴

What changes the answer for you: your treatment format, your dose, your starting hematocrit, your age, smoking, living at high altitude, and whether you have untreated sleep apnea. ¹, ⁵, ²

First, check for anything urgent

⁶, ⁷, ¹

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

This page is for you if you're an adult man on prescribed TRT and your hematocrit came back high, you were told to donate blood, or your clinic paused your refill. It also helps if you're about to start TRT and want to know what to watch.

Don't use this page instead of medical care if you have the warning symptoms above. Call 911 for chest pain, sudden trouble breathing or stroke signs; seek prompt medical care for new one-sided leg symptoms. If you're trying to have a baby soon, tell your prescriber and a urologist or reproductive urologist: testosterone therapy can lower sperm production. That fertility discussion does not replace review of the high hematocrit. ⁶, ⁷, ¹

This guide covers prescribed testosterone for adult men with hypogonadism. It is not a treatment guide for women, adolescents, gender-affirming care or nonmedical testosterone use; those settings need the appropriate clinician and population-specific guidance.

---

What hematocrit level is too high on TRT?

The Endocrine Society calls for prescriber-led action at a hematocrit above 54% during TRT. Before starting, it flags above 48% (above 50% at high altitude) as a higher-risk finding; the European Association of Urology (EAU) also calls for careful assessment of starting values around 48–50%. Between those lines, a rising number deserves review, not panic. ¹, ⁵

Hematocrit is the share of your blood volume made of red blood cells. A result of 52% means about 52% of your blood volume is red cells. The rest is mostly plasma, the liquid part. It's measured on a complete blood count (CBC), the same test that shows hemoglobin, the oxygen-carrying protein inside red cells. The two usually rise together. ²

Some reports use a fraction: 0.52 L/L is the same as 52%. Hemoglobin uses different units, such as g/dL; do not compare that number with a hematocrit percentage.

Here's the confusing part. You'll see 48, 50, 52 and 54 thrown around online like they all mean the same thing. They don't. Each number comes from a different source and does a different job. We lined them up:

Sources: ¹, ⁵, ³, ²

Two things this table won't tell you, and they matter:

54.0% is not permission to wait. The Endocrine Society says "above 54%," while the EAU contraindication table includes 54% itself. A number sitting right at the line, or climbing fast toward it, needs your prescriber's eyes now. ¹, ⁵

Your own starting point counts. A jump from 42% to 51% is a bigger change than sitting at 49% for two years. The Endocrine Society says plainly that the exact hematocrit level where clot or stroke risk goes up "is not known." That's why both the trend and the number matter. ¹

Does high hematocrit on TRT mean you'll get a blood clot?

No single number predicts a clot, but a high hematocrit isn't something to brush off. In a large U.S. records study, men on TRT who reached 52% or higher in their first year had more events in a combined heart-and-clot outcome than men who didn't. The study shows a link, not proof that the high count caused those problems. ³

More red cells make blood thicker. Thicker blood is the worry. Here's what these studies show, translated into plain numbers:

Sources: ³, ⁸, ⁹

The clot percentages in TRAVERSE were numerically higher with testosterone gel. That is not proof that hematocrit caused those clots, and the heart-event result does not make every TRT regimen risk-free.

Can you feel high hematocrit? Sometimes. MedlinePlus lists symptoms of too many red blood cells, like headache, dizziness, a red face, itching after a shower, heavy sweating and blurry vision. But those are common and vague. Only a blood test can tell you where you stand. ²

What about the 2025 label changes? In February 2025, FDA requested removal of the boxed-warning language about increased cardiovascular events and added or strengthened blood-pressure warnings. The hematocrit warnings stayed. Every current label we checked still tells prescribers to check hematocrit and act when it rises. FDA's June 2026 update request concerns age-related hypogonadism, prostate cancer and enlarged prostate wording; it is not an instruction to stop hematocrit monitoring. ¹⁰, ¹¹, ⁴, ¹², ¹³, ¹⁴, ⁹

Could your hematocrit result be falsely high?

Sometimes a high percentage reflects less plasma rather than extra red cells; dehydration is one example. MedlinePlus calls dehydration the most common cause of a high result overall, but that does not establish the cause of a high result during TRT. Smoking and high altitude can also raise hematocrit, and those are not simply lab errors. ², ¹⁵

That doesn't mean you should dismiss a high result. It means you should give your prescriber the full picture so they can decide whether a repeat test makes sense. Here's a quick checklist:

Sources: ², ¹, ⁵

Follow your lab's instructions about fluids and fasting before a blood test. Don't "water-load" to push a number down. A diluted reading just hides the problem from the person trying to help you.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

What happens when hematocrit is high on TRT? Will you have to stop?

Your prescriber may pause or lower the testosterone dose, look for other causes like sleep apnea, and recheck. A restart may be possible once the number comes down, but four product labels say that if the same product is restarted and again causes elevated hematocrit, that product should be stopped permanently. ¹, ⁴, ¹², ¹³, ¹⁴

This is the detail a general restart rule can miss. General guidelines and product labels address different levels of detail; a product-specific restriction is not a contradiction of the guideline.

We compared the current labels for five FDA-approved products with the Endocrine Society and EAU guidance, side by side. These are instructions for prescribers, not steps to carry out yourself:

Sources: ¹, ⁵, ⁴, ¹², ¹³, ¹⁴, ⁹

What this means for you: If one of those four products is restarted and again causes a rise, its label calls for ending that product. It doesn't ban all testosterone forever, but another treatment still needs a fresh clinical decision. Compounded testosterone has no FDA-approved, product-specific prescribing information; that is not an exemption from hematocrit monitoring or testosterone's known risks. ⁴, ¹², ¹³, ¹⁴, ¹⁶

That's why the exact product belongs in the conversation. Ask yours which guideline and product warning they're following, and why.

What prescribers usually do

None of these are steps to take on your own. They're what to expect, so you can ask good questions.

1. Confirm the result. A repeat CBC, especially if the first one was borderline or you were dehydrated.
2. Pause until it comes down. The Endocrine Society says "until hematocrit decreases to a safe level." Labels say "an acceptable concentration."
3. Review the dose and schedule. The rise is tied to dose and testosterone level; a different schedule alone is not a proven solution for every patient.
4. Change the treatment format. More on that below.
5. Look for other causes. Sleep apnea, smoking, lung or heart conditions, altitude.
6. Remove blood (therapeutic phlebotomy). The Endocrine Society calls it effective. It's a tool, not a full plan.
7. Dig deeper if there's no clear reason. If your count stays high and nothing explains it, ask whether a blood specialist (hematologist) should take a look. A high hematocrit isn't the same thing as polycythemia vera, a bone marrow disease, but a persistent unexplained rise is worth checking. ¹, ⁵, ¹⁵

How long until it comes down after a pause? It varies, and we couldn't find a reliable timeline to give you. Ask your prescriber what change they expect and when the recheck will confirm it.

What should you send your prescriber right now?

Send your dated CBC, your earlier results, the exact name of your testosterone product, and any recent blood donations or dose changes. Then ask four things: what's causing it, what changes now, when the recheck is, and who will review the result with you.

A high number with no plan attached is frustrating. "Just donate blood" isn't a plan. This message gives you a way to ask for one. Copy it, fill in the blanks, and send it through your clinic's secure portal.

Hello. My CBC dated ______ shows a hematocrit of ______%. The lab's reference range is ______. My earlier result was ______% on ______. My prescribed testosterone product is ______ (exact name and form). Recent blood donations, prescribed phlebotomy, dose changes or symptoms that may matter: ______. Could you tell me how soon this needs review, whether a repeat test or other causes need checking, and what I should do before my next scheduled dose? What's the follow-up date, and who will review the result with me?

A complete plan has four parts. Before you hang up or close the chat, make sure you have:

Don't use a portal message for emergency symptoms. Those go to 911.

Need help sorting out where this care should come from? If your current prescriber is giving you that four-part plan, you have a clear next step. If not, TRT Provider Guide's Find My TRT Path tool helps you organize your situation and the questions to ask, whether you stay, get a second opinion, or look for care that monitors more closely. It doesn't read lab results, diagnose anything, or promise a prescription. Keep your lab values and identifying health details in your clinic's secure channel, not in the tool; read our Privacy Policy. Map my next step with Find My TRT Path

Should you donate blood on TRT to lower hematocrit?

Blood removal can lower hematocrit, but a high result is not a reason to arrange repeated donations on your own. Your prescriber should decide whether blood removal belongs in your plan, and the blood center must decide whether you can donate. The Red Cross's standard whole-blood interval is at least 8 weeks; that is a donor rule, not a TRT treatment schedule. ¹, ¹⁷, ¹⁸

There are two different things people call "donating blood":

Sources: ¹⁸, ¹, ⁵

Before booking, ask whether the center can carry out your clinician's order, what paperwork it needs, and whether there is a fee. If a donor center turns you away, ask your clinician where prescribed blood removal can be arranged; do not hide TRT use or a high result from donor staff.

Here's the catch. In a small Canadian study, 12 of 27 repeat donors on TRT still had hemoglobin of at least 180 g/L at later donations. The researchers measured hemoglobin, not a repeated CBC hematocrit; their approximate conversion is not a substitute for your lab result. A separate U.S. donor study found that donations were associated with lower hemoglobin over a year. Neither study proves that routine donation prevents TRT-related clots. Donation lowers the number. It doesn't fix why the number went up. ¹⁷, ¹⁹

And every donation removes iron. The Red Cross says frequent donors may want to talk with their doctor about iron. Iron is needed to make new red cells, and a ferritin test (a measure of your stored iron) answers a different question than hematocrit. Some men on TRT end up with a high hematocrit and low iron at the same time. If you donate often, ask whether iron testing makes sense. Don't start iron pills or step up donations on your own. ²⁰

Can water, aspirin or supplements fix a high hematocrit?

None is a substitute for finding the cause and following a plan. Normal hydration can correct a dehydration-related rise, but water does not remove extra red cells, and aspirin or "blood flow" supplements are not established treatments for TRT-related erythrocytosis. ², ¹, ²¹

Quick answers to the shortcuts you'll see online:

• Drinking more water: Correcting dehydration can change a concentrated reading. Extra water is not a treatment for true red cell buildup.
• Aspirin: MedlinePlus warns aspirin raises bleeding risk and interacts with other medicines. Don't start it for this unless your clinician tells you to. If it is already prescribed for another reason, ask that clinician before changing it. ²¹
• Supplements: The guidelines and studies cited here do not establish a supplement that treats TRT-related erythrocytosis or prevents clots from it. Tell your prescriber everything you take. ¹, ⁵

Why does TRT raise hematocrit, and who's most at risk?

Testosterone signals your bone marrow to make more red blood cells, and the effect grows with the dose and your testosterone level. The Endocrine Society says the rise is bigger in older men. A higher starting hematocrit and conditions such as smoking, high altitude or untreated sleep apnea also belong in the risk review. ¹, ⁵, ²

This isn't a rare glitch. The Endocrine Society's own review of gel trials found men on testosterone were about 8 times more likely than men on placebo to go above 54% (relative risk 8.14, with a wide 95% confidence interval of 1.87–35.40). That is a relative comparison in the gel trials reviewed, not the chance that an individual patient will cross 54%. It calls erythrocytosis, the medical word for too many red cells, the most common adverse event in testosterone trials. ¹

Who's at higher risk:

• A high starting number. A 2025 Swiss study found that patients with higher starting hematocrit tended to have higher values later. This was a retrospective study, not a personal risk calculator. ²²
• Older age. The Endocrine Society says the increase is greater in older men.
• Higher doses and peaks. Injections tend to cause bigger rises than gels (see below).
• Untreated sleep apnea. The Endocrine Society tells clinicians to check for it when hematocrit goes over 54%, and lists untreated severe sleep apnea as a reason not to start TRT at all.
• Smoking and high altitude. Both shift what's normal for you.

A word on sleep apnea. If you snore loudly, wake up gasping, or someone has seen you stop breathing at night, ask about a sleep study. Testosterone labels warn that TRT can worsen sleep apnea in men with risk factors like obesity. And untreated sleep apnea can push hematocrit up on its own. Two forces, one number. ¹, ⁹

Which type of testosterone raises hematocrit the least?

In the comparisons below, short-acting testosterone injections showed larger hematocrit rises than gels or nasal testosterone. Every format can raise it. The studies differ in size, length and definitions, so treat this as a direction, not a promise. ²³, ²⁴, ²⁵

We pulled the hematocrit numbers from each FDA label's own trial data, then added the head-to-head studies. FDA-approved products and compounded products are kept separate on purpose.

FDA-approved products (label trial data)

Sources: ⁴, ¹², ¹⁴, ⁹

The labels themselves warn that rates from different trials can't be directly compared. Trials ran for different lengths and counted "increase" differently. These are reported adverse events or stated thresholds, not the percentage of patients whose hematocrit rose by any amount.

Head-to-head studies (smaller, observational)

Sources: ²³, ²⁴, ²⁵

These studies did not randomly assign treatment. The Pastuszak groups also differed in age and starting blood counts, so their percentages cannot predict your own risk.

Compounded testosterone (not FDA-approved)

Some online programs prescribe compounded testosterone cypionate, creams or troches. Compounded drugs are not FDA-approved. FDA doesn't review them for safety, effectiveness or quality before they're sold. The FDA-approved product trials above cannot establish the hematocrit risk of a different compounded preparation. ¹⁶, ²⁶, ²⁷, ²⁸

The name "testosterone cypionate" alone does not tell you whether a dispensed product is FDA-approved or compounded. Ask for the exact manufacturer or compounding pharmacy and the product details before comparing evidence. ²⁹, ²⁶

What about daily microdosing? Some programs say small daily injections keep levels steady and help with red blood cells. The studies cited here do not prove that daily injections lower hematocrit compared with other schedules. It's a reasonable question to ask your prescriber. It's not a proven fix.

Our take: If your hematocrit keeps climbing on injections, ask whether an FDA-approved gel or nasal product is an option for you, and whether your insurance covers it. But no format lets you skip the blood tests. ¹, ⁵, ⁹

How often should hematocrit be checked on TRT?

The schedule depends on your exact product and risk, not which rule you prefer. Several FDA labels say about every 3 months; the Endocrine Society says at 3–6 months and then yearly, while the EAU recommends checks at 3, 6 and 12 months, then yearly. After a high result, the next check is your prescriber's call, not just the next date on a routine calendar. ¹, ⁵, ⁴, ¹², ¹³, ¹⁴

The routine schedules are the starting point. A high result changes the plan. The EAU calls for closer checks in people at higher risk of elevated hematocrit. Ask for the exact recheck date. ⁵

For the full routine schedule by product and guideline, see how often you should get bloodwork on TRT.

Is your online TRT clinic actually checking your hematocrit?

Public pages can show what a clinic promises, not whether every patient receives it. On October 5, 2026, Hone Health's clinical policy listed hematocrit and 90-day follow-up; Male Excel's listed lab markers did not name hematocrit, and the Taurus Meds pages we could inspect did not specify a follow-up panel. None of that proves how a clinic would manage your current high result. ³⁰, ³¹, ³²

This is a question to ask before something goes wrong. A program can only catch a rising hematocrit if it measures it. So we read each program's own pages.

What we actually verified

Checked: October 5, 2026.

Sources: The programs' public TRT, pricing, product and clinical-policy pages; Male Excel and Taurus Meds terms; current prescribing information on DailyMed; Endocrine Society and EAU guidance.

Confirmed as published, not confirmed in patient care: Hone lists HCT, two separate testosterone readings, and follow-up testing and consults every 90 days. Its injection, cream and troche pages call those products compounded. Male Excel lists testosterone, estradiol, thyroid, DHEA-S and PSA, with blood testing every 6 months and 60-day assessments. We checked the listed prices and recalculated the examples below.

Provider claims, not established clinical findings: Male Excel's statement that daily dosing helps regulate red blood cell levels; Taurus Meds' broad FDA-approved-medications claim and testosterone-increase marketing.

Not established by this review: A high-hematocrit treatment protocol for any program; whether an unlisted CBC is ordered; the cost of every extra CBC or visit; each reader's state eligibility; or actual response, refill and records-transfer times. We did not test checkout, contact support, audit patient records or independently verify individual clinician or pharmacy licenses. Taurus's linked intake did not expose a readable clinical protocol.

Method: How We Review TRT Providers

Sources: ³⁰, ³³, ²⁶, ²⁷, ²⁸, ³¹, ³⁴, ³⁵, ³², ³⁶

A few notes so the table doesn't mislead you:

• Hone's two plans differ. Its clinical policy says patients agree to follow-up testing every 90 days. Its pricing says the $25/month Basic plan includes labs every 6 months. The cost above uses Premium. Do not assume Basic includes the same TRT access or monitoring: ask which plan, lab panel and follow-up schedule apply before paying. ³⁰, ³³
• Hone's medication price is a starting price. "From $28/mo" depends on your prescription. Cream and troches start at $60/month, plus the required membership. ³³
• Male Excel's injection plan bundles thyroid tablets and lists a 60-day supply billed every other month. Its price can change with your dose. Thyroid medication is a separate treatment, not testosterone; ask why it is included and what the quote would be for the plan actually prescribed. ³⁴
• Taurus Meds markets "2-5x your testosterone." On a page about a side effect that rises with testosterone level, that's worth asking about directly. It is a marketing claim, not a personal treatment goal. Its terms name partner pharmacies, but a partner list does not establish which pharmacy or exact product would fill your prescription. ³², ³⁶

A high result can add costs not settled by a membership headline: a repeat CBC, clinician review, outside referral, sleep testing or prescribed blood removal. The examples above assume 12 unchanged monthly charges, not a guarantee that therapy continues for 12 months. We did not establish every extra lab, confirmation-test, consultation, shipping, tax or treatment-pause charge. Ask for those answers in writing, including whether billing continues during a clinical hold and how to obtain your records before a transfer.

Five questions to ask any TRT clinic about hematocrit:

1. Is hematocrit or a full CBC included when my blood count is due for review? Look for the test by name, not just "comprehensive labs."
2. How often in the first year, and after this high result? Look for a written interval tied to your product and risk, not a one-size-fits-all calendar.
3. What finding makes you pause or change my plan? Look for the applicable guideline and product warning, plus a response to a rising trend; some labels do not give a numerical cutoff.
4. If I need phlebotomy, who orders it and where? Good answer: they write the order or refer you.
5. Will you assess possible sleep apnea and other causes? Look for a way to arrange further testing when the history or result warrants it.

The honest tradeoff with Hone

The Hone injection, cream and troche pages we checked describe those products as compounded. We did not establish an FDA-approved testosterone option from those pages. If discussing an FDA-approved gel or nasal product is your priority, ask your current prescriber or a urologist or endocrinologist about it, and check insurance coverage separately. ²⁶, ²⁷, ²⁸

Hone's published clinical policy names hematocrit and 90-day follow-up, which is useful disclosure. But its testosterone page also lists polycythemia among reasons treatment may not be right for someone. A published monitoring schedule is not evidence that Hone—or either other program—will accept or appropriately manage an existing high count. ³⁰, ²⁶

Before paying a new clinic, resolve the high-result plan. Use the five questions above with your current prescriber or the clinician giving a second opinion. Ask a prospective program whether it can coordinate that plan before buying a test or membership; a new intake is not a replacement for follow-up.

Your clinic paused TRT or only says "donate blood." What now?

A pause does not always mean the end of TRT, but restarting depends on the cause, your follow-up results and the exact product label. If your clinic only says "donate" without explaining the cause or the next check, ask for a real plan. If no one takes ownership of it, get another medical opinion. ¹, ⁴, ¹², ¹³, ¹⁴

It's frustrating to be told to stop something that's finally working. A pause is a safety step, not by itself a final verdict on whether TRT is right for you.

Sources: ¹, ⁵, ⁴, ¹², ¹³, ¹⁴

About online care: Testosterone is a Schedule III controlled substance and requires a valid prescription. As checked October 5, 2026, a DEA/HHS extension allows appropriately authorized DEA-registered clinicians to prescribe Schedule II–V medicines through qualifying audio-video telemedicine without a prior in-person exam through December 31, 2026. Applicable federal and state requirements still apply, and a clinician or program may require an in-person assessment; an online questionnaire alone is not the required clinical visit. ⁴, ³⁷

Restarting, switching, or just not sure which way to go? TRT Provider Guide's Find My TRT Path tool lays out your care-route options and the questions to ask each one, based on your situation, fertility plans, state and budget. It's educational and doesn't interpret your hematocrit. Find your care route with Find My TRT Path

Starting TRT and worried about hematocrit?

Ask for a baseline CBC before you start. If your hematocrit is already above 48% (or above 50% if you live at high altitude), the Endocrine Society calls for evaluation before treatment. Ask any program, before you pay, how often it will check hematocrit and what it does if it climbs. ¹

A CBC does not diagnose low testosterone. That diagnosis needs compatible symptoms or signs plus consistently low testosterone, confirmed with appropriate repeat early-morning testing; the Endocrine Society specifies fasting measurements. A symptom quiz, one low test or a single cutoff is not enough. ³⁸

A short pre-start checklist:

• A baseline CBC, and a copy of the result for your own records
• A sleep apnea screen if you snore or wake up tired
• Your smoking status and where you live (altitude matters)
• A treatment format you've discussed, including FDA-approved options
• The hematocrit check schedule, in writing
• A plan for fertility if children are in your future

See which tests come first in what blood tests are required before TRT.

How did we research this page?

We compared current prescribing information and specialty guidance with published research and provider policies on October 5, 2026. We kept a lab flag, a research cutoff, a guideline action point and a product-specific restart warning separate, because they answer different questions.

The sources we inspected included the Endocrine Society and EAU guidelines; current DailyMed labels for Xyosted, Jatenzo, Kyzatrex, Tlando and AndroGel 1.62%; the TRAVERSE and Ory study reports available through their published abstracts and product labeling; the formulation and donation studies; American Red Cross and MedlinePlus information; and the provider pages cited below. The tables preserve each source's population, time frame and limits rather than treating unlike findings as one risk estimate.

What this page is: a source-checked guide. What it isn't: a hands-on review, a clinical study, or medical advice. We didn't examine patients, sign up for programs, or test anyone's support line. No clinician has reviewed this version of the page. Every fact on provider pricing and labs is dated because it can change. Our full method is in How We Review TRT Providers. See our Editorial Standards or report a correction. For the broader picture, see our pages on TRT safety and monitoring and TRT side effects.

TRT and high hematocrit: frequently asked questions

A high result needs context: your symptoms, prior CBCs, product and follow-up plan all matter. These answers explain general evidence; your prescriber must decide what your own result means.

Is a hematocrit of 52 on TRT dangerous?

It's above many labs' normal range, and one large study linked 52% or higher in the first year to more combined heart-and-clot events. It is not a personal clot prediction or a reason to wait until 54%. Ask your prescriber about the trend, a recheck and whether the treatment plan needs review. ², ³, ¹

Is 54% hematocrit an emergency?

A hematocrit of 54% alone does not tell you whether emergency care is needed. Contact your prescriber promptly, get instructions before your next scheduled dose, and follow any urgent lab directions. Call 911 for chest pain, sudden trouble breathing, or stroke signs; feeling well does not mean a high result can be ignored. ¹, ⁵, ⁶, ⁷

Should I stop TRT if my hematocrit is high?

Follow any hold instructions your clinician has already given you; otherwise contact them before your next dose rather than changing treatment yourself. Above 54%, the Endocrine Society recommends a prescriber-directed hold, evaluation of other causes and possible restart at a lower dose once the level is safe. The exact product label can add restrictions. ¹, ⁴, ¹², ¹³, ¹⁴

Does donating blood fix high hematocrit on TRT?

It lowers the number for a while. It doesn't fix the cause, and repeated donations remove iron. The Red Cross's standard whole-blood interval is at least 8 weeks, but the center must decide whether you are eligible and your clinician must decide whether blood removal is needed. ¹⁷, ²⁰, ¹⁸

Does drinking more water lower hematocrit?

Correcting dehydration can lower a concentrated reading. Water doesn't remove the extra red cells testosterone makes, and dehydration should not be assumed to explain a high result during TRT. ², ¹

Do daily injections lower hematocrit?

Some programs say so, but the studies cited here do not prove that daily injections lower hematocrit compared with other schedules. Small comparisons found smaller rises with gel or nasal treatment than with short-acting injections; they do not establish a guaranteed fix. ²³, ²⁴, ²⁵

Does switching to a gel solve it?

Not guaranteed. Gels tend to raise hematocrit less than short-acting injections in the studies discussed here, but the AndroGel 1.62% label still warns about it and calls for regular checks. ²³, ⁹

Can sleep apnea cause high hematocrit on TRT?

It can add to it. The Endocrine Society tells clinicians to check for sleep apnea when hematocrit goes above 54%. Testosterone labels also warn TRT can worsen sleep apnea in men with risk factors. ¹, ⁹

Is high hematocrit on TRT the same as polycythemia vera?

No. Hematocrit is a measurement. Polycythemia vera is a specific bone marrow disease. Testosterone can cause secondary erythrocytosis, but a high result does not establish that it is the only cause. A persistent, unexplained rise is worth a deeper look. ¹, ¹⁵

Can I have high hematocrit and low iron at the same time?

Yes. Hematocrit measures your share of red cells; ferritin measures stored iron. Frequent blood removal can lower iron. Tell your prescriber about past donations and ask whether iron testing makes sense. ²⁰

How long does it take hematocrit to come down after a pause?

It varies, and we couldn't find a reliable timeline to share. Ask your prescriber what change they expect and when your recheck will confirm it.

Can Find My TRT Path read my lab results?

No. It's an educational tool that helps you organize care-route questions. Send your lab report to your prescriber through their secure channel. Do not enter your lab values or identifying health details into Find My TRT Path.

---

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Educational information, not medical advice. If you have chest pain, sudden trouble breathing, or signs of a stroke, call 911. Last verified October 2026.

---

Sources

Sources were checked October 5, 2026. Provider pages establish what the company publishes, not independently verified clinical practice.

1. Endocrine Society clinical practice guideline (2018), recommendations 1.1, 2.2, Table 2, monitoring table and erythrocytosis discussion.
2. MedlinePlus, Hematocrit Test, interpretation, symptoms and preparation.
3. Ory et al., Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy, Journal of Urology (2022), abstract and results.
4. XYOSTED prescribing information, revised July 2025, sections 5.1 and 6.1.
5. European Association of Urology, Male Hypogonadism (2026), sections 3.4.1 and 3.5, Tables 3.4 and 3.6.
6. CDC, Signs and Symptoms of Stroke.
7. CDC, About Venous Thromboembolism (Blood Clots), symptoms and when to seek care.
8. Lincoff et al., Cardiovascular Safety of Testosterone-Replacement Therapy, New England Journal of Medicine (2023), abstract and results.
9. AndroGel 1.62% prescribing information, revised October 2025, sections 5.2, 5.3 and 6.1.
10. FDA, Class-wide labeling changes for testosterone products, February 28, 2025.
11. FDA, Testosterone Information, June 2026 requested prescribing-information updates.
12. JATENZO prescribing information, revised September 2025, sections 5.1 and 6.1.
13. KYZATREX prescribing information, revised August 2026, section 5.1.
14. TLANDO prescribing information, revised February 2026, sections 5.1 and 6.1.
15. NHS, Erythrocytosis, relative/absolute erythrocytosis and polycythaemia vera.
16. FDA, Understanding the Risks of Compounded Drugs.
17. Chin-Yee et al., Blood donation and testosterone replacement therapy, Transfusion (2017), abstract and results.
18. American Red Cross, Blood Donor Eligibility Criteria, donation intervals and blood-count requirements.
19. Hazegh et al., Blood donors receiving testosterone replacement therapy at a large USA blood service organization, Transfusion (2020), abstract and results.
20. American Red Cross, Iron and Blood Donation.
21. MedlinePlus, Aspirin, precautions and adverse effects.
22. Neidhart et al., Prevalence and predictive factors of testosterone-induced erythrocytosis, Frontiers in Endocrinology (2025), results and Table 2.
23. Pastuszak et al., Comparison of the Effects of Testosterone Gels, Injections, and Pellets, Sexual Medicine (2015), methods and results.
24. Best et al., Cross-sectional comparison of nasal testosterone gel and intramuscular testosterone cypionate, CUAJ, published online 2020; journal issue 2021.
25. Reddy et al., Matched-cohort analysis of intranasal gel, injections and pellets, CUAJ (2023), methods and results.
26. Hone Health, Testosterone Cypionate, compounded-drug disclosure and contraindication list; provider-stated.
27. Hone Health, Testosterone Cream, compounded-drug disclosure; provider-stated.
28. Hone Health, Testosterone Troches, compounded-drug disclosure; provider-stated.
29. DailyMed, DEPO-TESTOSTERONE (testosterone cypionate), Pharmacia & Upjohn, product identity and approved-application marketing status.
30. Hone Health, Clinical Policy, initial testing and 90-day follow-up requirements; provider-stated.
31. Male Excel, TRT Online, published lab markers, six-month testing, 60-day reviews and in-person-exam disclaimer; provider-stated.
32. Taurus Meds, homepage, medication and testosterone-increase marketing claims; provider-stated.
33. Hone Health, Testosterone Replacement Therapy, test price, medication starting prices and Basic/Premium plan comparison; provider-stated.
34. Male Excel, Hormone Replacement Therapy Costs, injectable package, membership, shipping and supply interval; provider-stated.
35. Male Excel, Terms & Conditions, subscriptions and terms of sale; provider-stated.
36. Taurus Meds, Terms of Use, sections 7, 8 and 28, and partner-pharmacy list; provider-stated.
37. DEA, Fourth Temporary Extension of telemedicine flexibilities, December 31, 2025 announcement.
38. Endocrine Society, Statement on Testosterone Replacement Therapy, July 16, 2026.